Another target for acute leukemias is the histone–lysine N-methyltransferase 2A (KMT2A) gene, previously referred to as the MLL (mixed-lineage leukemia or myeloid/lymphoid) gene, which can undergo translocations with different partner genes. The gene discussed is KMT2A; the disease is acute leukemia.